Kourtidou, C.; Rafailidis, V.; Varouktsi, G.; Kanakis, E.; Liakopoulos, V.; Vyzantiadis, T.-A.; Savopoulos, C.; Marinaki, S.; Stangou, M.; Tziomalos, K.
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage. J. Pers. Med. 2023, 13, 536.
https://doi.org/10.3390/jpm13030536
AMA Style
Kourtidou C, Rafailidis V, Varouktsi G, Kanakis E, Liakopoulos V, Vyzantiadis T-A, Savopoulos C, Marinaki S, Stangou M, Tziomalos K.
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage. Journal of Personalized Medicine. 2023; 13(3):536.
https://doi.org/10.3390/jpm13030536
Chicago/Turabian Style
Kourtidou, Christodoula, Vasileios Rafailidis, Garyfallia Varouktsi, Efthimios Kanakis, Vassilios Liakopoulos, Timoleon-Achilleas Vyzantiadis, Christos Savopoulos, Smaragdi Marinaki, Maria Stangou, and Konstantinos Tziomalos.
2023. "Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage" Journal of Personalized Medicine 13, no. 3: 536.
https://doi.org/10.3390/jpm13030536
APA Style
Kourtidou, C., Rafailidis, V., Varouktsi, G., Kanakis, E., Liakopoulos, V., Vyzantiadis, T.-A., Savopoulos, C., Marinaki, S., Stangou, M., & Tziomalos, K.
(2023). Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage. Journal of Personalized Medicine, 13(3), 536.
https://doi.org/10.3390/jpm13030536
